119 related articles for article (PubMed ID: 2497402)
1. Putaminal haemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator.
Brückmann H; Ferbert A
Neuroradiology; 1989; 31(1):95-7. PubMed ID: 2497402
[TBL] [Abstract][Full Text] [Related]
2. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
Wolpert SM; Bruckmann H; Greenlee R; Wechsler L; Pessin MS; del Zoppo GJ
AJNR Am J Neuroradiol; 1993; 14(1):3-13. PubMed ID: 8427107
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report.
Jafar JJ; Tan WS; Crowell RM
J Neurosurg; 1991 May; 74(5):808-12. PubMed ID: 1901602
[TBL] [Abstract][Full Text] [Related]
4. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
5. Influence of haemorrhagic transformation on the outcome of thrombolytic therapy for patients with acute brain embolism.
Okada Y; Sadoshima S; Saku Y; Kitazono T; Irie K; Ogasawara T; Utsunomiya H; Fujishima M
Neurol Res; 1992; 14(2 Suppl):167-70. PubMed ID: 1355879
[No Abstract] [Full Text] [Related]
6. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.
del Zoppo GJ; Poeck K; Pessin MS; Wolpert SM; Furlan AJ; Ferbert A; Alberts MJ; Zivin JA; Wechsler L; Busse O
Ann Neurol; 1992 Jul; 32(1):78-86. PubMed ID: 1642475
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
[TBL] [Abstract][Full Text] [Related]
8. Early computed tomographic findings for thrombolytic therapy in patients with acute brain embolism.
Okada Y; Sadoshima S; Nakane H; Utsunomiya H; Fujishima M
Stroke; 1992 Jan; 23(1):20-3. PubMed ID: 1731415
[TBL] [Abstract][Full Text] [Related]
9. Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator.
Kissel P; Chehrazi B; Seibert JA; Wagner FC
J Neurosurg; 1987 Sep; 67(3):399-405. PubMed ID: 3112329
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches.
Sasaki O; Takeuchi S; Koike T; Koizumi T; Tanaka R
Neurosurgery; 1995 Feb; 36(2):246-52; discussion 252-3. PubMed ID: 7731503
[TBL] [Abstract][Full Text] [Related]
11. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion.
Yoneyama T; Nakano S; Kawano H; Iseda T; Ikeda T; Goya T; Wakisaka S
AJNR Am J Neuroradiol; 2002 Feb; 23(2):277-81. PubMed ID: 11847054
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
[TBL] [Abstract][Full Text] [Related]
13. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.
Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM
Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513
[TBL] [Abstract][Full Text] [Related]
14. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.
Mori E; Yoneda Y; Tabuchi M; Yoshida T; Ohkawa S; Ohsumi Y; Kitano K; Tsutsumi A; Yamadori A
Neurology; 1992 May; 42(5):976-82. PubMed ID: 1579252
[TBL] [Abstract][Full Text] [Related]
15. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
[TBL] [Abstract][Full Text] [Related]
16. Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke. A case report.
Yasaka M; Yamaguchi T; Yonehara T; Moriyasu H
Angiology; 1994 Jun; 45(6):481-4. PubMed ID: 8203776
[TBL] [Abstract][Full Text] [Related]
17. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
[TBL] [Abstract][Full Text] [Related]
18. [Acute embolic stroke treated with rt-PA during elective coronary angiography].
Ascer E; Lessa I; Caldas JG; Frudit ME; Pereira Mde B; Baruzzi AC
Arq Bras Cardiol; 1996 Sep; 67(3):171-3. PubMed ID: 9181710
[TBL] [Abstract][Full Text] [Related]
19. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
20. [Direct continuous observation of in situ thrombolysis in the cerebral embolic model of rabbits].
Kashiwabara S; Kurokawa Y; Uede T; Hashi K
No To Shinkei; 1998 Apr; 50(4):347-54. PubMed ID: 9592824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
